Gouvernance Alnylam Pharmaceuticals, Inc.

ALNY

US02043Q1076

Produits pharmaceutiques

Marché Fermé - Nasdaq 22:00:00 06/10/2026			Varia. 5j.	Varia. 1 janv.
223,94 ^USD	+1,84%		-11,86%	-43,68%

17/09	Transcript : Alnylam Pharmaceuticals, Inc. - Special Call
14/09	Transcript : Alnylam Pharmaceuticals, Inc. Presents at Morgan Stanley 24th Annual Global Healthcare Conference, Sep-14-2026 10:00 AM

Comité Exécutif: Alnylam Pharmaceuticals, Inc.

Dirigeant

Fonctions occupéesDepuis

Yvonne Greenstreet

63 ans

Chief Executive Officer

01/01/2022

Bryan Supran

General Counsel	01/09/2025
Corporate Secretary	01/09/2025

Melissa McLaughlin

Human Resources Officer

01/01/2025

Timothy J. Maines

Chief Tech/Sci/R&D Officer

01/04/2023

Piyush Sharma

Compliance Officer

21/09/2022

Jeffrey Poulton

58 ans

Comptroller/Controller/Auditor	13/08/2019
Director of Finance/CFO	13/08/2019

Kevin Fitzgerald

58 ans

Chief Tech/Sci/R&D Officer

01/09/2016

Joshua Brodsky

Investor Relations Contact	01/02/2021
Public Communications Contact	01/02/2021

Pushkal Garg

58 ans

Chief Tech/Sci/R&D Officer

29/10/2014

Composition du Conseil d'Administration: Alnylam Pharmaceuticals, Inc.

Administrateur

ComitésDepuis

Amy Schulman

65 ans

Compensation Committee	01/07/2015
HR Committee
Governance Committee
Nominating Committee
Audit Committee	12/01/2026
Compensation Committee Chair	25/01/2021
Finance Committee	12/01/2026

Colleen Reitan

66 ans

Audit Committee	25/09/2019
Compensation Committee Chair
HR Committee Chair
Compensation Committee	26/08/2019
Finance Committee	25/09/2019
Governance Committee Chair	25/09/2019
Nominating Committee Chair	25/09/2019

David Pyott

72 ans

Executive Committee	07/04/2011
Governance Committee Chair
Nominating Committee Chair
Compensation Committee	18/02/2026
Governance Committee	18/02/2026
Nominating Committee	18/02/2026

Dennis Ausiello

80 ans

Governance Committee
Nominating Committee	30/12/2021
Audit Committee	30/12/2021
Compensation Committee	30/12/2021
Finance Committee	30/12/2021

Charles Sigal

74 ans

Governance Committee	08/06/2020
Nominating Committee	08/06/2020
Compensation Committee
HR Committee

Stuart Arbuckle

60 ans

Executive Committee
Compensation Committee	06/02/2026
Governance Committee Chair
Nominating Committee Chair

Olivier Brandicourt

70 ans

Audit Committee	22/01/2024
Compensation Committee	02/03/2020
HR Committee	02/03/2020

Margaret Hamburg

70 ans

Governance Committee	10/01/2019
Nominating Committee	10/01/2019

Benjamin Cravatt

56 ans

Compensation Committee Chair

01/01/2014

Peter Kellogg

69 ans

Audit Committee Chair

29/09/2023

Yvonne Greenstreet

63 ans

Director/Board Member

28/10/2021

Dernières Nominations: Alnylam Pharmaceuticals, Inc.

27/05	Alnylam Pharmaceuticals, Inc. élit Benjamin F. Cravatt en tant qu'administrateur de classe III et membre du comité scientifique et technologique du conseil d'administration, avec effet au 1er juin 2026	CI
06/04	BioCryst Pharmaceuticals nomme Sandeep M. Menon au poste de Chief Research and Development Officer	CI
08/01	Praxis Precision Medicines, Inc. annonce des changements au sein de sa direction	CI
15/12	Bourse : Orange accélère en Espagne, Sanofi et ArgenX subissent des revers, ServiceNow a des vues sur Armis
10/12	Elevance Health nomme Amy Schulman administratrice indépendante à compter du 12 janvier 2026	CI
03/12	Alnylam Pharmaceuticals annonce des changements au sein de son conseil d'administration	CI
03/12	Alnylam Pharmaceuticals annonce des changements au sein de son conseil d'administration	RE

Plus d'Actualités

Anciens Dirigeants et Administrateurs: Alnylam Pharmaceuticals, Inc.

Insider

Fonctions occupées

DepuisJusqu'au

Michael Bonney

Director/Board Member	05/01/2023	02/12/2025
Chairman	01/12/2015	05/01/2023
Independent Dir/Board Member	17/12/2014	05/01/2023

Steven A. Bossone

Corporate Officer/Principal

01/08/2010

01/08/2025

Phillip Sharp

Director/Board Member	14/06/2002	08/05/2025
Founder	14/06/2002	08/05/2025
Independent Dir/Board Member	14/06/2002	08/05/2025

Akshay Vaishnaw

Chief Tech/Sci/R&D Officer	01/01/2006	04/01/2022
Corporate Officer/Principal	02/10/2023	01/12/2024
President	04/01/2022	02/10/2023

James Bilotta

Chief Tech/Sci/R&D Officer

01/10/2015

01/08/2024

Sara Nochur

General Counsel	01/01/2006	01/01/2021
Corporate Officer/Principal	01/01/2021	01/05/2024

Marsha Fanucci

Director/Board Member	08/12/2010	29/09/2023
Independent Dir/Board Member	08/12/2010	29/09/2023

Al Boyle

Chief Tech/Sci/R&D Officer

01/12/2015

01/04/2023

Steven Paul

Director/Board Member	22/09/2010	16/04/2022
Independent Dir/Board Member	22/09/2010	16/04/2022

John Maraganore

Director/Board Member	01/12/2002	31/12/2021
Chief Executive Officer	01/12/2002	31/12/2021
Founder	01/12/2002	31/12/2021
President	01/12/2002	01/12/2007

Laurie Keating

General Counsel	17/09/2014	10/09/2021
Corporate Secretary	17/09/2014	10/09/2021

Barry Greene

Chief Operating Officer	01/10/2003	19/09/2016
President	01/10/2003	30/09/2020

Paul Schimmel

Director/Board Member	14/06/2002	06/05/2020
Founder	14/06/2002	06/05/2020
Independent Dir/Board Member	14/06/2002	06/05/2020

Nereyda Garcia

Compliance Officer

01/01/2016

01/12/2019

Mike Mason

Comptroller/Controller/Auditor	01/12/2005	01/10/2018
Director of Finance/CFO	02/12/2005	01/06/2016
Treasurer	01/02/2011	01/02/2019

John Clarke

Director/Board Member	14/06/2002	10/01/2019
Chairman	14/06/2002	01/01/2016
Founder	14/06/2002	10/01/2019
Independent Dir/Board Member	14/06/2002	10/01/2019

Karen Anderson

Human Resources Officer

17/09/2014

01/01/2019

Kevin Starr

Director/Board Member	01/09/2003	01/03/2018
Independent Dir/Board Member	01/09/2003	01/03/2018

David-Alexandre Gros

Director of Finance/CFO	01/07/2016	06/01/2017
Corporate Officer/Principal	08/06/2015	01/07/2016

Mark Baglin

Sales & Marketing

01/01/2017

Benny Sorensen

Chief Tech/Sci/R&D Officer

01/07/2015

01/10/2016

Susanna High

Director/Board Member	01/02/2007	01/06/2008
Corporate Officer/Principal	01/06/2008	01/09/2016

Emmanuel Dulac

Corporate Officer/Principal

19/08/2016

Oved Amitay

Corporate Officer/Principal

27/06/2012

01/06/2016

Laurence Reid

Corporate Officer/Principal

04/06/2010

31/12/2014

Marko Kinchen Kozul

Corporate Officer/Principal

17/09/2014

Victor Dzau

Director/Board Member	01/04/2007	30/06/2014
Independent Dir/Board Member	01/04/2007	30/06/2014

Varun Kumar

Corporate Officer/Principal

01/04/2011

01/02/2014

Pritesh Gandhi

Chief Tech/Sci/R&D Officer

01/01/2014

Aria Tavana

Corporate Officer/Principal

01/01/2013

Nessan Bermingham

Corporate Officer/Principal

30/04/2012

Dinah Sah

Chief Tech/Sci/R&D Officer	01/04/2005	01/01/2012
Private Equity Investor	01/01/2010	01/01/2012

Kenneth S. Koblan

Chief Tech/Sci/R&D Officer	20/12/2010	02/06/2011
Corporate Officer/Principal	04/06/2010	20/12/2010

Vicki Sato

Director/Board Member

01/12/2005

30/04/2011

Patricia Allen

Director of Finance/CFO	01/05/2004	27/09/2010
Treasurer	01/05/2004	28/02/2011

James L. Vincent

Director/Board Member

01/07/2005

22/09/2010

Garvin L. Warner

Corporate Officer/Principal

01/08/2010

Ed Scolnick

Director/Board Member

01/02/2008

01/02/2010

Antonin Rollet de Fougerolles

Chief Tech/Sci/R&D Officer

01/01/2003

01/01/2010

Jason Rhodes

Corporate Officer/Principal

01/07/2007

01/01/2010

John Schmidt

Chief Tech/Sci/R&D Officer

01/10/2008

30/09/2009

Peter J. Williams

Corporate Officer/Principal

01/01/2006

Nagesh Mahanthappa

Corporate Officer/Principal

01/08/2002

01/02/2007

Eric W. Raichle

Human Resources Officer

01/01/2007

Mary DeLena

Corporate Officer/Principal

01/01/2007

John Berriman

Director/Board Member

01/07/2003

07/12/2005

Cynthia Clayton

Investor Relations Contact

01/01/2005

Robert A. Millman

Corporate Officer/Principal

09/09/2004

Lubomir Nechev

Corporate Officer/Principal

01/01/2004

Thomas R. Ulich

Chief Tech/Sci/R&D Officer

01/01/2003

01/01/2004

Vincent J. Miles

Corporate Officer/Principal

01/07/2003

David M. Konys

Corporate Officer/Principal

01/04/2003

Rachel Meyers

Chief Tech/Sci/R&D Officer

01/04/2003

Victor E. Kotelianski

Corporate Officer/Principal

01/04/2003

Peter Barrett

Director/Board Member

01/07/2002

Zachary A. Zimmerman

Corporate Officer/Principal

David Altreuter

Corporate Officer/Principal

Christoph Westphal

Director/Board Member	-	-
Founder	-	-

Edward E. Harlow

Corporate Officer/Principal

Jian Xin Chen

Corporate Officer/Principal

Jürgen Soutschek

Chief Tech/Sci/R&D Officer

Eric Ruby

General Counsel

Roy Lobb

Corporate Officer/Principal

David Neafus

Director of Finance/CFO

Mary D. Trueblood

Comptroller/Controller/Auditor

Ulrich Bodner

Corporate Officer/Principal

Stuart Pollard

Corporate Officer/Principal

Philip Chase

General Counsel

Jeffrey Behrens

Corporate Officer/Principal

Kathryn Morris

Public Communications Contact

Donna T. Ward

Corporate Officer/Principal

Distribution de l'Âge des Dirigeants

Parité Homme Femme

Homme	20
Femme	5

Dont comité exécutif

Homme	8
Femme	1

Dont Administrateurs

Homme	9
Femme	2

Révisions

Recommandations analystes

Évolution recommandations analystes 1 an

Évolution recommandations analystes 4 mois

Objectif analystes

Évolution objectif analystes 1 an

Évolution objectif analystes 4 mois

ESG MSCI

Environnement

Social

Gouvernance

Polémique

Controverses Ethiques

Non

Controverses sur les droits de l'Homme

Non

Controverses Subventions fiscales

Non

Conforme à la finance Islamique

Non

Alnylam Pharmaceuticals, Inc. est une entreprise biopharmaceutique spécialisée dans le développement, la fabrication et la commercialisation de produits thérapeutiques basé sur la technologie de l'interférence par ARN, La société propose des traitements de maladies rares et chroniques, notamment les maladies cardiovasculaires, la porphyrie hépatique aiguë, l'hypercholestérolémie et l'amylose à transthyrétine avec atteinte neurologique. A fin 2025, Alnylam Pharmaceuticals, Inc dispose d'un portefeuille de 5 produits en phase de commercialisation et de plusieurs candidats en phase de développement clinique. La répartition géographique du CA est la suivante : Etats-Unis (69,2%), Europe (21,8%) et autres (9%).

Employés

2 500

Secteur

Produits pharmaceutiques

Plus d'informations sur la société